Glacier FarmMedia COVID-19 & the Farm

EU may restrict vaccine exports

WINNIPEG, Jan. 27 (MarketsFarm) – The following is a glance at the news moving markets in Canada and globally.

– While pharmaceutical giants Pfizer and AstraZeneca are still grappling with delays in producing their COVID-19 vaccines, the European Union has warned it could restrict exports of vaccine made inside the bloc to other countries. EU Health Commissioner Stella Kyriakides has said that companies making vaccines inside the EU must “provide early notification whenever they want to export vaccines to third countries”. “That will be very disturbing, of course,” Canadian Prime Minister Justin Trudeau said in French earlier this morning. “We are communicating with our partners in Europe to make sure the contracts signed by Canada are respected.” More than 230,000 doses of the Moderna vaccine, produced outside the EU in Switzerland and the United States, are expected to be delivered to Canada next week.

– The Senate trial of former U.S. President Donald Trump will go ahead after its members voted 55-45 yesterday to set aside an objection to the proceedings. The result of the vote declares the trial to be constitutional. All 50 Democrats voted in favour, as well as five Republicans. However, a two-thirds majority (67 Senators) is needed to convict Trump, which now seems unlikely.

– Thousands of Indian farmers stormed the country’s famous Red Fort yesterday to protest against new agricultural laws from Prime Minister Narendra Modi’s government. The protests turned violent as one person died, while 300 police officers and several demonstrators were injured. The farmers, mostly from the Sikh minority, are urging the government to repeal new legislation which they say would benefit large-scale agri-business. The government had offered not to impose the laws for 18 months, but the farmers want a full repeal.

COPA Medallion COPA finalist in 2012, 2014 and 2015.
©2021 AGCanada is a production of Glacier FarmMedia Limited Partnership. Any affiliated or third party content is the property of its respective owner and is used with permission.
Please refer to Copyright Page for details.
Click here to view our Website Terms of Use.